Title : The Antipancreatic Cancer Activity of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2.

Pub. Date : 2015 Oct

PMID : 26284306






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The Antipancreatic Cancer Activity of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2. OSI 027 CREB regulated transcription coactivator 2 Mus musculus
2 In the present study, we investigated the potential activity of OSI-027, a potent and selective mammalian target of rapamycin (mTOR) complex 1/2 (mTORC1/2) dual inhibitor, against pancreatic cancer cells both in vitro and in vivo. OSI 027 CREB regulated transcription coactivator 2 Mus musculus
3 At the molecular level, OSI-027 treatment blocked mTORC1 and mTORC2 activation simultaneously, without affecting ERK-mitogen-activated protein kinase activation. OSI 027 CREB regulated transcription coactivator 2 Mus musculus